Drug manufacturer to launch commercial version of ‘natural painkiller’ Palmitoylethanolamide (PEA)

A large U.S. pharmaceutical company is preparing to go to market with a mass-produced commercial version of a natural pain management supplement that compounding pharmacies in Australia have been providing to integrative doctors and their patients for many years – Palmitoylethanolamide, or PEA. In November the drug manufacturer, Gencor, announced it had recently completed a 

Continue Reading…

Forgotten pain-killing drug could fill gap in the market left by codeine crackdown

With codeine products no longer available over the counter at Australian chemists from today (1 Feb 2018), the compounding pharmacy sector may have a gentler, non-addictive answer for sufferers of chronic pain. The alternative pain-killing medication has a name that’s enough to cause you some additional pain – Palmitoylethanolamide. In clinical trials, this curious old 

Continue Reading…